The Hematopathology of HIV-1 Disease: Experimental Analysis in Vivo

  • Joseph M. Mccune
  • Hideto Kaneshima
Part of the Medical Intelligence Unit book series (MIU.LANDES)


The human immunodeficiency virus (HIV-1) is the etiologic agent of the acquired immune deficiency syndrome (AIDS). As the AIDS epidemic has spread worldwide, the prevailing focus has been on several salient features: first, that the disease is acquired (how can it be avoided?), and secondly, that it results in immunodeficiency (what are the immunopathologic correlates and how can they be reversed?). Far less attention has been devoted to the fact that HIV-1 infection produces a syndrome in which immunodeficiency is but one manifestation. Given the dramatic presentation of visibly end-stage patients, this emphasis is clinically sound. In terms of understanding pathogenesis, however, it is less useful. By analogy, the mechanistic basis of hypertension is not understood upon analysis of its end-stage sequelae: strokes and myocardial infarcts; likewise, the presentation of ketoacidosis does not immediately suggest a pancreatic β-cell defect in insulin production. To understand the syndrome of HIV-1 disease, it is perhaps more appropriate to expand our preclinical studies towards the basic pathogenic mechanisms of the virus which occur early in the course of disease, and which eventually lead to the clinical manifestations of immunodeficiency, wasting, neurological disorders, etc. In this manner, common reducible pathways may be delineated which would allow treatments to prevent late stage AIDS.


Human Immunodeficiency Virus Human Immunodeficiency Virus Type Human Immunodeficiency Virus Infection SCID Mouse Acquire Immune Deficiency Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Zon LI, Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). Sem Hematol 1988; 25: 208–18.Google Scholar
  2. 2.
    Scadden DT, Zon LI, Groopman JE. Pathophysiology and management of HIV-associated hematologic disorders. Blood 1989; 74: 1455–63.PubMedGoogle Scholar
  3. 3.
    Aboulafia DM, Mitsuyasu RT. Hematologic abnormalities in AIDS. Hematol Oncol Clin North Am 1991; 5: 195–214.PubMedGoogle Scholar
  4. 4.
    Calenda V, Chermann JC. The effects of HIV on hematopoiesis. Eur J Haematol 1992; 48: 181–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Zauli G, Davis BR. Role of HIV infection in the hematologic manifestations of HIV seropositive subjects. Crit Rev Onc/Hem 1993; 15: 271–83.Google Scholar
  6. 6.
    Mir N, Castello C, Luckit J et al. HIV-disease and bone marrow changes: a study of 60 cases. Eur J Haematol 1989; 42: 339–43.PubMedCrossRefGoogle Scholar
  7. 7.
    Outwater E, McCutchan JA. Neutrophil-associated antibodies and granulocytopenia in AIDS. Clin Res 1985; 33: 413A.Google Scholar
  8. 8.
    Murphy MF, Metcalfe P, Waters AH et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987; 66: 337–48.PubMedCrossRefGoogle Scholar
  9. 9.
    McCance-Katz EF, Hoecker JL, Vitale NB. Severe neutropenia associated with anti-neutrophil antibody in a patient with acquired immunodeficiency syndrome-related complex. Pediatr Inf Dis J 1987; 6: 417–9.Google Scholar
  10. 10.
    Morris L, Distenfeld A, Amorosi E et al. Auto-immune thrombo cytopenic purpura in homosexual men. Ann Intern Med 1982; 96: 714–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Ratnoff OD, Menitove JE, Aster RH et al. Coincident classic hemophilia and “idiopathic” thrombocytopenic purpura in patients under treatments with concentrates of antihemophilic factor (Factor VIII). N Engl J Med 1983; 308: 439–42.PubMedCrossRefGoogle Scholar
  12. 12.
    Walsh C, Krigel R, Lennette E et al. Thrombocytopenia in homosexual patients: prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 542–54.PubMedCrossRefGoogle Scholar
  13. 13.
    Goldsweig HG, Grossman R, William D. Thrombocytopenia in homosexual men. Am J Hematol 1986; 21: 243–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Stella CC, Gauser A, Hoelzer D. Defective in vitro growth of hematopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest 1987; 80: 286–93.PubMedCrossRefGoogle Scholar
  15. 15.
    Leiderman IZ, Greenberg ML, Adelsberg BR et al. A glycoprotein inhibition of in vitro granulopoiesis associated with AIDS. Blood 1987; 70: 1267–72.PubMedGoogle Scholar
  16. 16.
    Balleari E, Timitilli S, Puppo F et al. Impaired in vitro growth of peripheral blood hematopoietic progenitor cells in HIV-infected patients: evidence of an inhibitory effect of autologous T lymphocytes. Ann Hematol 1991; 63: 320–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Zauli G, Re MC, Visani G et al. Evidence for a human immunodeficiency virus type 1–mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis 1992; 166: 710–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Louache F, Henri A, Bettaieb A et al. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992; 80: 2991–9.PubMedGoogle Scholar
  19. 19.
    Stanley SK, Kessler SW, Justement JS et al. CD34’ bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 1992; 149: 689–97.PubMedGoogle Scholar
  20. 20.
    Re MC, Zauli G, Furlini G et al. The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication. Arch Virol 1993; 129: 53–64.PubMedCrossRefGoogle Scholar
  21. 21.
    Molina JM, Scadden DT, Sakaguchi M et al. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood 1990; 76: 2476–82.PubMedGoogle Scholar
  22. 22.
    Zauli G, Re MC, Davis BR et al. Impaired in vitro growth of purified (CD34`) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood 1992; 79: 2680–7.PubMedGoogle Scholar
  23. 23.
    Lunardi-Iskandar Y, Georgoulias V, Bertoli AM et al. Impaired in vitro proliferation of hemopoietic precursors in HIV-1–infected subjects. Leuk Res 1989; 13: 573–81.PubMedCrossRefGoogle Scholar
  24. 24.
    Bagnara GP, Zauli G, Re MC et al. Impaired GM-CSF production by cultured light density mononuclear cells and T lymphocytes correlates with the number of circulating CFU-GM in HIV-1 seropositive subjects. Int J Cell Cloning 1991; 9: 239–50.PubMedCrossRefGoogle Scholar
  25. 25.
    Spivak JL, Bender BS, Quinn TC. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med 1984; 77: 224–28.PubMedCrossRefGoogle Scholar
  26. 26.
    Franco CM, Hendrix LE, Lokey JL. Bone marrow abnormalities in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 275–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Abrams DI, Chinn EK, Lewis BJ et al. Hematologic manifestations in homosexual men with Kaposi’s sarcoma. Am J Clin Pathol 1984; 81: 13–8.PubMedGoogle Scholar
  28. 28.
    Osborne BM, Guarda LA, Butler JJ. Bone marrow biopsies in patients with the acquired immunodeficiency syndrome. Hum Pathol 1984; 15: 1048–1057.PubMedCrossRefGoogle Scholar
  29. 29.
    Geller SA, Muller R, Greenberg ML et al. Acquired immunodeficiency syndrome: defective features of bone marrow biopsies. Arch Pathol Lab Med 1985; 109: 138–41.PubMedGoogle Scholar
  30. 30.
    Castella A, Croxson TS, Mildvan D et al. The bone marrow in AIDS: a histologic, hematologic, and microbiologic study. Am J Clin Pathol 1985; 84: 425–32.PubMedGoogle Scholar
  31. 31.
    Schneider DR, Picker LJ. Myelodysplasia in the acquired immunodeficiency syndrome. Am J Clin Pathol 1985; 84: 144–52.PubMedGoogle Scholar
  32. 32.
    Shenoy CM, Lin JH. Bone marrow findings in acquired immunodeficiency syndrome (AIDS). Am J Med Sci 1986; 292: 372–82.PubMedCrossRefGoogle Scholar
  33. 33.
    Treacy M, Lai L, Costello C et al. Peripheral blood and bone marrow abnormalities in patients with HIV related disease. Br J Haematol 1987; 65: 289–94.PubMedCrossRefGoogle Scholar
  34. 34.
    Stutte HJ, Muller H, Falk S et al. Pathophysiological mechanisms of HIV-induced defects in haematopoiesis: pathology of the bone marrow. Res Virol 1990; 141: 195–200.PubMedCrossRefGoogle Scholar
  35. 35.
    Kaloutsi V, Kohlmeyer U, Maschek H et al. Comparison of bone marrow and hematologic findings in patients with human immunodeficiency virus infection and those with myelodysplastic syndromes and infectious diseases. Am J Clin Pathol 1994; 101: 123–9.PubMedGoogle Scholar
  36. 36.
    Wickramasinghe SN, Beatty C, Shiels S et al. Ultrastructure of the bone marrow in HIV infection: evidence of dyshaemopoiesis and stromal cell damage. Clin Lab Haematol 1992; 14: 213–29.PubMedCrossRefGoogle Scholar
  37. 37.
    Joshi V, Oleske JM. Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children. Arch Pathol Lab Med 1985; 109: 142–6.PubMedGoogle Scholar
  38. 38.
    Schuurman HJ, Krone WJA, Broekhuizen R et al. The thymus in acquired immune deficiency syndrome: comparison with other types of immunodeficiency disease, and presence of components of human immunodeficiency virus type 1. Am J Pathol 1989; 131: 1329–34.Google Scholar
  39. 39.
    De Rossi A, Calabro ML, Panozzo M et al. In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. Aids Res Hum Retroviruses 1990; 6: 287–98.PubMedCrossRefGoogle Scholar
  40. 40.
    Tremblay M, Numazaki K, Goldman H et al. Infection of human thymic lymphocytes by HIV-1. J Acquir Immune Defic Syndr 1990; 3: 356–60.PubMedGoogle Scholar
  41. 41.
    D’Andrea V, Ambrogi V. Thymus biopsy in patients with AIDS and ARC. Thymus 1991; 18: 61–2.PubMedGoogle Scholar
  42. 42.
    Courgnaud V, Laure F, Brossard A et al. Frequent and early in utero HIV-1 infection. Aids Res Hum Retroviruses 1991; 7: 337–41.PubMedCrossRefGoogle Scholar
  43. 43.
    Rosenzweig M, Clark DP, Gaulton GN. Selective thymocyte depletion in neonatal HIV-1 thymic infection. Aids 1993; 7: 1601–5.PubMedCrossRefGoogle Scholar
  44. 44.
    Chervenak R, Dempsey D, Soloff R et al. The expression of CD4 by T cell precursors resident in both the thymus and the bone marrow. J Immunol 1993; 151: 4486–93.PubMedGoogle Scholar
  45. 45.
    Galy A, Verma S, Barcena A et al. Precursors of CD3’CD4’CD8’ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development. J Exp Med 1993; 178: 391–401.PubMedCrossRefGoogle Scholar
  46. 46.
    Kraft DL, Weissman IL, Waller EK. Differentiation of CD3–4–8– human fetal thymocytes in vivo: characterization of a CD3–4’8– intermediate. J Exp Med 1993; 178: 265–77.PubMedCrossRefGoogle Scholar
  47. 47.
    Schmitt C, Ktorza S, Sarun S et al. CD34–expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. Blood 1993; 82: 3675–85.PubMedGoogle Scholar
  48. 48.
    Lunardi-Iskandar Y, Nugeyre MT, Georgoulias V et al. Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells. J Clin Invest 1989; 83: 610–15.PubMedCrossRefGoogle Scholar
  49. 49.
    Schnittman SM, Denning SM, Greenhouse JJ et al. Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCRaß and TCRyS to human immunodeficiency virus infection: a mechanism for CD4’ (T4) lymphocyte depletion. Proc Nati Acad Sci USA 1990; 87: 7727–31.CrossRefGoogle Scholar
  50. 50.
    Valentin H, Nugeyre MT, Vuillier F et al. Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro. J Virol 1994; 68: 3041–50.PubMedGoogle Scholar
  51. 51.
    Su L, Kaneshima H, Bonyhadi ML et al. HIV-1–indusced thymocyte depletion is associated with indirect cytophicity and infection of progenitor cells in vivo. Immunity 1995; 2: 25–36.PubMedCrossRefGoogle Scholar
  52. 52.
    Baskin GB, Murphy-Corb M, Martin LN et al. Thymus in simian immunodeficiency virus-infected rhesus monkey. Lab Invest 1991; 65: 400–7.PubMedGoogle Scholar
  53. 53.
    Beebe AM, Dua N, Faith TG et al. Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J Virol 1994; 68: 3080–91.PubMedGoogle Scholar
  54. 54.
    Bonyhadi ML, Rabin L, Salimi S et al. HIV induces thymus depletion in vivo. Nature 1993; 363: 728–32.PubMedCrossRefGoogle Scholar
  55. 55.
    Aldrovandi GM, Feuer G, Gao L et al. The SCID-hu mouse as a model for HIV-1 infection. Nature 1993; 363: 732–6.PubMedCrossRefGoogle Scholar
  56. 56.
    Stanley SK, McCune JM, Kaneshima H et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993; 178: 1151–63.PubMedCrossRefGoogle Scholar
  57. 57.
    Armstrong JA, Horne R. Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet 1984; ii:370–2.Google Scholar
  58. 58.
    Harper ME, Marselle LM, Gallo RC et al. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci USA 1986; 83: 772–6.PubMedCrossRefGoogle Scholar
  59. 59.
    Schuurman HJ, Krone WJ, Broekhuizen R et al. Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals. Am J Pathol 1988; 133: 516–24.PubMedGoogle Scholar
  60. 60.
    Wood GS, Burns BF, Dorfman RF et al. In situ quantitation of lymph node helper, suppressor, and cytotoxic T cell subsets in AIDS. Blood 1986; 67: 596–603.PubMedGoogle Scholar
  61. 61.
    Pantaleo G, Graziosi C, Demarest JF et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362: 355–8.PubMedCrossRefGoogle Scholar
  62. 62.
    Embretson J, Zupancic M, Ribas JL et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993; 362: 359–62.PubMedCrossRefGoogle Scholar
  63. 63.
    Torok-Storb B. Cellular interactions. Blood 1988; 72: 373–85.PubMedGoogle Scholar
  64. 64.
    Moore MAS. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991; 78: 1–19.PubMedGoogle Scholar
  65. 65.
    Mayani H, Guilbert LJ, Janowska WA. Biology of the hemopoietic microenvironment. Eur J Haematol 1992; 49: 225–33.PubMedCrossRefGoogle Scholar
  66. 66.
    Metcalf D. Hemopoietic regulators. Trends Biochem Sci 1992; 17: 286–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Koury MJ. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 1992; 20: 391–4.PubMedGoogle Scholar
  68. 68.
    Avraham H. Regulation of megakaryocytopoiesis. Stem Cells 1993; 11: 499–510.PubMedCrossRefGoogle Scholar
  69. 69.
    Schofield R. The relationship between the spleen colony-forming cells and the haemopoietic stem cell. Blood Cells 1978; 4: 7–25.PubMedGoogle Scholar
  70. 70.
    Frassoni F, Testa NG, Lord BI. The relative spatial distributions of erythroid progenitor cells (BFU-e and CFU-e) in the normal mouse femur. Cell Tissue Kinet 1982; 15: 447–55.PubMedGoogle Scholar
  71. 71.
    Lord BI, Wright EG. Spatial organization of CFU-S proliferation regulators in the mouse femur. Leuk Res 1984; 8: 1073–83.PubMedCrossRefGoogle Scholar
  72. 72.
    Ikuta K, Uchida N, Friedman J et al. Lymphocyte development from stem cells. Annu Rev Immunol 1992; 10: 759–83.PubMedCrossRefGoogle Scholar
  73. 73.
    Baum CM, Weissman IL, Tsukamoto AS et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89: 2804–8.CrossRefPubMedGoogle Scholar
  74. 74.
    DiGiusto D, Chen S, Combs J et al. Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 1994; 84: 421–32.Google Scholar
  75. 75.
    Wineman JP, Gilmore GL, Gritzmacher C et al. CD4 is expressed on murine pluripotent hematopoietic stem cells. Blood 1992; 80: 1717–24.PubMedGoogle Scholar
  76. 76.
    Fredrickson GG, Basch RS. L3T4 antigen expression by hemopoietic precursor cells. J Exp Med 1989; 169: 1473–8.CrossRefGoogle Scholar
  77. 77.
    Lansdorp PM. Subpopulations of cells that express CD34. Blood 1989; 74S: 13a.Google Scholar
  78. 78.
    Zauli G, Vitale M, Re MC et al. In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line. Blood 1994; 83: 167–75.PubMedGoogle Scholar
  79. 79.
    Kessler SW, Vembu D, Black AT. Large-scale purification and characterization of CD34–positive hematopoietic progenitor cells. Blood 1987; 70S: 321a.Google Scholar
  80. 80.
    Folks TM, Kessler SW, Orenstein JM et al. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 1988; 242: 919–22.PubMedCrossRefGoogle Scholar
  81. 81.
    Von Laer D, Hufert FT, Fenner TE et al. CD34’ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood 1990; 76: 1281–6.Google Scholar
  82. 82.
    Kitano K, Abboud CN, Ryan DH et al. Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood 1991; 77: 1699–705.PubMedGoogle Scholar
  83. 83.
    Steinberg HN, Crumpacker CS, Chatis PA. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol 1991; 65: 1765–9.PubMedGoogle Scholar
  84. 84.
    Zauli G, Re MC, Visani G et al. Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34’) hematopoietic progenitor cells. Arch Virol 1992; 122: 271–80.PubMedCrossRefGoogle Scholar
  85. 85.
    Davis BR, Schwartz DH, Marx JC et al. Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol 1991; 65: 1985–90.PubMedGoogle Scholar
  86. 86.
    De Luca A, Teofili L, Antinori A et al. Haemopoietic CD34’ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol 1993; 85: 20–4.CrossRefPubMedGoogle Scholar
  87. 87.
    Burstein Y, Rashbaum WK, Hatch WC et al. Alterations in human fetal hematopoiesis are associated with maternal HIV infection. Pediatr Res 1992; 32: 155–9.PubMedCrossRefGoogle Scholar
  88. 88.
    Cen D, Zauli G, Szarnicki R et al. Effect of different human immunodeficiency virus type-1 (HIV-1) isolates on long-term bone marrow haemopoiesis. Br J Haematol 1993; 85: 596–602.PubMedCrossRefGoogle Scholar
  89. 89.
    Zucker-Franklin D, Cao Y. Megakaryocytes of human immuno deficiency virus-infected individuals express viral RNA. Proc Natl Acad Sci USA 1989; 86: 5595–9.PubMedCrossRefGoogle Scholar
  90. 90.
    Basch RS, Kouri YH, Karpatkin S. Expression of CD4 by human megakaryocytes. Proc Natl Acad Sci USA 1990; 87: 8085–9.PubMedCrossRefGoogle Scholar
  91. 91.
    Monte D, Groux H, Raharinivo B et al. Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha. Blood 1992; 79: 2670–9.PubMedGoogle Scholar
  92. 92.
    Kouri YH, Borkowsky W, Nardi M et al. Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1. Blood 1993; 81: 2664–70.PubMedGoogle Scholar
  93. 93.
    Lucey DR, Dorsky DI, Nicholson-Weller A et al. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med 1989; 169: 327–31.CrossRefPubMedGoogle Scholar
  94. 94.
    Freedman AR, Gibson FM, Fleming SC et al. Human immunodeficiency virus infection of eosinophils in human bone marrow cultures. J Exp Med 1991; 174: 1661–4.PubMedCrossRefGoogle Scholar
  95. 95.
    Kunzi MS, Groopman JE. Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells. Blood 1983; 81: 3336–42.Google Scholar
  96. 96.
    Geissler RG, Ganser A, Ottmann OG et al. Bone marrow derived fibroblasts from HIV-infected patients inhibit in vitro hematopoietic colony growth. Ann Hematol 1993; 675: A38.Google Scholar
  97. 97.
    McElrath MJ, Pruett JE, Cohn ZA. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci USA 1989; 86: 675–9.PubMedCrossRefGoogle Scholar
  98. 98.
    Potts BJ, Hoggan MD, Lamperth L et al. Replication of HIV-1 and HIV-2 in human bone marrow cultures. Virology 1992; 188: 840–9.PubMedCrossRefGoogle Scholar
  99. 99.
    Scadden DT, Zeira M, Woon A et al. Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990; 76: 317–22.PubMedGoogle Scholar
  100. 100.
    Steinberg HN, Anderson J, Crumpacker CS et al. HIV infection of the BS-1 human stroma cell line: effect on murine hematopoiesis. Virology 1993; 193: 524–7.PubMedCrossRefGoogle Scholar
  101. 101.
    Geissler RG, Ottmann OG, Kleiner K et al. Decreased haematopoietic colony growth in long-term bone marrow cultures of HIV-positive patients. Res Virol 1993; 144: 69–73.PubMedCrossRefGoogle Scholar
  102. 102.
    Schwartz GN, Kessler SW, Francis ML et al. Negative regulators may mediate hematopoietic suppression in HIV-infected bone marrow long term cultures. In: Guigon M et al eds. The negative regulation of hematopoiesis. Colloque INSERM/John Libbey Eurotext Ltd 1993: 403–5.Google Scholar
  103. 103.
    Kaczmarski RS, Davison F, Blair E et al. Detection of HIV in haemopoietic progenitors. Br J Haematol 1992; 82: 764–9.PubMedCrossRefGoogle Scholar
  104. 104.
    Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991; 12: 102–5.PubMedCrossRefGoogle Scholar
  105. 105.
    Terai C, Kornbluth RS, Pauza CD et al. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991; 87: 1710–5.PubMedCrossRefGoogle Scholar
  106. 106.
    Banda NK, Bernier J, Kurahara DK et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992; 176: 1099–106.PubMedCrossRefGoogle Scholar
  107. 107.
    Groux H, Torpier G, Monte D et al. Activation-induced death by apoptosis in CD4’ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175: 331–40.PubMedCrossRefGoogle Scholar
  108. 108.
    Meyaard L, Otto SA, Jonker RR et al. Programmed death of T cells in HIV-1 infection. Science 1992; 257: 217–9.PubMedCrossRefGoogle Scholar
  109. 109.
    Zauli G, Re MC, Furlini G et al. Evidence for an HIV-1 mediated suppression of in vitro growth of enriched (CD34*) hematopoietic progenitors. J Acquir Immune Defic Syndr 1991; 4: 1251–3.PubMedGoogle Scholar
  110. 110.
    Zauli G, Re MC, Furlini G et al. Human immunodeficiency virus type 1 envelope glycoprotein gp120–mediated killing of human haematopoietic progenitors (CD34* cells). J Gen Virol 1992; 73: 417–21.PubMedCrossRefGoogle Scholar
  111. 111.
    Zauli G, Vitale M, Davis BR et al. Human immunodeficiency virus type-1 triggers apoptotic cell death of hematopoietic progenitor (CD34*) cells. In: Guigon M, ed. The negative regulation of hematopoiesis. Colloque INSERM/John Libbey Eurotext Ltd 1993: 401.Google Scholar
  112. 112.
    Donahue RE, Johnson MM, Zon LI et al. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature 1987; 326: 200–5.PubMedCrossRefGoogle Scholar
  113. 113.
    Sugiura K, Oyaizu N, Pahwa R et al. Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood. Blood 1992; 80: 1463–9.PubMedGoogle Scholar
  114. 114.
    Sporn MB, Roberts AB. Transforming growth factor-ß: multiple actions and potential clinical applications. JAMA 1989; 262: 938–44.PubMedCrossRefGoogle Scholar
  115. 115.
    Wright EG, Sheridan P, Moore MAS. An inhibitor of murine stem cell proliferation produced by normal human bone marrow. Leuk Res 1980; 4: 309–14.PubMedCrossRefGoogle Scholar
  116. 116.
    Broxmeyer HE, Williams DE, Lu L et al. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol 1986; 136: 4487–91.PubMedGoogle Scholar
  117. 117.
    Caux C, Saeland S, Favre C et al. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34* hematopoietic progenitor cells. Blood 1990; 75: 2292–8.PubMedGoogle Scholar
  118. 118.
    Landevirta J, Mauray CPJ, Teppo AM et al. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 289–91.CrossRefGoogle Scholar
  119. 119.
    Merrill JE, Koyanagi Y, Chen ISY. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989; 63: 4404–8.PubMedGoogle Scholar
  120. 120.
    Arditi M, Kabat W, Yogev R. Serum tumor necrosis factor alpha, interleukin 1–beta, p24 antigen concentrations and CD4* cells at various stages of human immunodeficiency virus-1 infection in children. Pediatr Inf Dis J 1991; 10: 450–5.CrossRefGoogle Scholar
  121. 121.
    Rautonen J, Rautonen N, Martin NL et al. Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection. Aids 1991; 5: 1319–25.PubMedCrossRefGoogle Scholar
  122. 122.
    Riechmann P, Poli G, Fox CH et al. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J Immunol 1991; 147: 2922–7.Google Scholar
  123. 123.
    Von Sydow M, Sonnerborg A, Gaines H et al. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. Aids Res Hum Retroviruses 1991; 7: 375–80.CrossRefGoogle Scholar
  124. 124.
    Noronha IL, Daniel V, Schimpf K et al. Soluble IL-2 receptor and tumor necrosis factor-alpha in plasma of haemophilia patients infected with HIV. Clin Exp Immunol 1992; 87: 287–92.PubMedCrossRefGoogle Scholar
  125. 125.
    Eyster ME, Goedert J, Poon MC et al. Acid-labile alpha interferon: a possible preclinical marker of the acquired immune deficiency syndrome in hemophilia. N Engl J Med 1983; 309: 583–86.PubMedCrossRefGoogle Scholar
  126. 126.
    Fuchs D, Hausen A, Reibnegger G et al. Interferon-7 concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J Acquir Immune Defic Syndr 1989; 2: 158–62.PubMedGoogle Scholar
  127. 127.
    Allen JB, Wong HL, Guyre PM et al. Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J Clin Invest 1991; 87: 1773–9.PubMedCrossRefGoogle Scholar
  128. 128.
    Wahl SM, Allen JB, McCartney FN et al. Macrophage-and astrocytederived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 1991; 173: 981–91.PubMedCrossRefGoogle Scholar
  129. 129.
    Kekow J, Wachsman W, McCutchan JA et al. Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci USA 1990; 87: 8321–5.PubMedCrossRefGoogle Scholar
  130. 130.
    Geissler RG, Ottmann OG, Eder M et al. Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected persons. Ann Hematol 1991; 62: 151–5.PubMedCrossRefGoogle Scholar
  131. 131.
    Geissler RG, Ottmann OG, Kojouharoff G et al. Influence of human recombinant interferon-alpha and interferon-gamma on bone marrow progenitor cells of HIV-positive individuals. Aids Res Hum Retroviruses 1992; 8: 521–5.PubMedCrossRefGoogle Scholar
  132. 132.
    Folks TM, Justement JS, Kinter A et al. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238: 800–2.PubMedCrossRefGoogle Scholar
  133. 133.
    Clouse KA, Cosentino LM, Weih KA et al. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 1991; 147: 2892–901.PubMedGoogle Scholar
  134. 134.
    Zauli G, Davis BR, Re MC et al. Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1–induced hematopoietic suppression. Blood 1992; 80: 3036–43.PubMedGoogle Scholar
  135. 135.
    Sastry KJ, Reddy HR, Pandita R et al. HIV-1 tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line. J Biol Chem 1990; 265: 20091–3.PubMedGoogle Scholar
  136. 136.
    Buonaguro L, Barillari G, Chang HK et al. Effects of the human immunodeficiency virus type 1 tat protein on the expression of inflammatory cytokines. J Virol 1992; 66: 7159–67.PubMedGoogle Scholar
  137. 137.
    Nakajima K, Martinez-Maza O, Hirano T et al. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol 1989; 142: 531–6.PubMedGoogle Scholar
  138. 138.
    Breen EC, Rezai AR, Nakajima K et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144: 480–4.PubMedGoogle Scholar
  139. 139.
    Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988; 55: 1189–93.PubMedCrossRefGoogle Scholar
  140. 140.
    Gardener TD, Flanagan P, Dryden MS et al. Disseminated Mycobacterium avium-intracellular infection and red cell hypoplasia in patients with the acquired immune deficiency syndrome. J Infect Dis 1988; 16: 135–40.Google Scholar
  141. 141.
    Gascon P, Sathe SS, Rameshwar P. Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex. Am J Med 1993; 94: 41–8.PubMedCrossRefGoogle Scholar
  142. 142.
    Weller TH, Hanshaw JB. Virologic and clinical observations on cytomegalic inclusion disease. N Engl J Med 1962; 266: 1233–5.PubMedCrossRefGoogle Scholar
  143. 143.
    Zuelzer WW, Mastrangelo R, Stulberg CS et al. Autoimmune hemolytic anemia: natural history and viral-immunologic interactions in childhood. Am J Med 1970; 49: 80–4.PubMedCrossRefGoogle Scholar
  144. 144.
    Zaia JA. The biology of human cytomegalovirus infection after bone marrow transplantation. Im J Cell Cloning 1986; 4: 135–41.CrossRefGoogle Scholar
  145. 145.
    Maciejewski JP, Bruening EE, Donahue RE et al. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1992; 80: 170–8.PubMedGoogle Scholar
  146. 146.
    Sing GK, Ruscetti FW. Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 1990; 75: 1965–73.PubMedGoogle Scholar
  147. 147.
    Reiser H, Kuhn J, Doerr HW et al. Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol 1986; 67: 2595–9.PubMedCrossRefGoogle Scholar
  148. 148.
    Danker WM, McCutchan JA, Richman DD et al. Localization of human cytomegalovirus in peripheral leukocytes by in situ hybridization. J Infect Dis 1990; 162: 31–36.CrossRefGoogle Scholar
  149. 149.
    Ibanez CE, Schrier R, Ghazal P et al. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991; 65: 6581–8.PubMedGoogle Scholar
  150. 150.
    Apperley JF, Dowding C, Hibbin J et al. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp Hematol 1989; 17: 38–45.PubMedGoogle Scholar
  151. 151.
    Rakusan TA, Juneja HS, Fleischmann WR. Inhibition of hemopoietic colony formation by human cytomegalovirus in vitro. J Inf Dis 1989; 159: 127–31.CrossRefGoogle Scholar
  152. 152.
    Lazzarotto T, Furlini G, Re MC et al. Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1. Arch Virol 1994; 135: 13–28.PubMedCrossRefGoogle Scholar
  153. 153.
    Marlink RG, Ricard D, M’Boup S. Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to HIV-2. AIDS Res Hum Retrovir 1988; 4: 137–48.PubMedCrossRefGoogle Scholar
  154. 154.
    Calenda V, Chermann JC. Severe in vitro inhibition of erythropoiesis and transient stimulation of granulopoiesis after bone-marrow infection with eight different HIV-2 isolates. Aids 1992; 6: 943–8.PubMedCrossRefGoogle Scholar
  155. 155.
    Zeldis JB, Mugishima H, Steinberg HN et al. In vitro hepatitis B virus infection of human bone marrow cells. J Clin Invest 1986; 78: 411–7.PubMedCrossRefGoogle Scholar
  156. 156.
    Busch FW, DeVos S, Flehmig B et al. Inhibition of in vitro hematopoiesis by hepatitis A virus. Exp Hematol 1987; 15: 978–82.PubMedGoogle Scholar
  157. 157.
    Zeldis JB, Boender PJ, Hellings JA et al. Inhibition of human hemopoiesis by non-A, non-B hepatitis virus. J Med Virol 1989; 27: 34–8.PubMedCrossRefGoogle Scholar
  158. 158.
    Nakao S, Lai CJ, Young NS. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood 1989; 74: 1235–40.PubMedGoogle Scholar
  159. 159.
    Young NS, Mortimer PP, Moore JG et al. Characterization of a virus that causes transient aplastic crisis. J Clin Invest 1984; 73: 224–30.PubMedCrossRefGoogle Scholar
  160. 160.
    McCune JM, Namikawa R, Kaneshima H et al. The SCID-hu mouse: a model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632–9.PubMedCrossRefGoogle Scholar
  161. 161.
    Bosma MJ, Carroll AM. The SCID mouse mutant: definition, characterization, and potential uses. Ann Rev Immunol 1991; 9: 325–50.CrossRefGoogle Scholar
  162. 162.
    Schuler W, Weiler IJ, Schuler A et al. Rearrangement of antigen receptor genes is defective in mice with severe combined immunodeficiency. Cell 1986; 46: 963–72.PubMedCrossRefGoogle Scholar
  163. 163.
    McCune JM, Namikawa R, Lieberman M et al. The SCID-hu mouse as a model system for HIV infection. In: Groopman JE, Chen ISY, Essex M eds. Human Retroviruses. New York: Alan R. Liss, Inc 1990: 347–59.Google Scholar
  164. 164.
    McCune JM. The rational design of animal models for HIV infection. Sem Virol 1990; 1: 229–35.Google Scholar
  165. 165.
    McCune JM, Kaneshima H, Krowka J et al. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Ann Rev Immunol 1991; 9: 399–429.CrossRefGoogle Scholar
  166. 166.
    McCune JM. HIV-1: the infective process in vivo. Cell 1991; 64: 351–63.PubMedCrossRefGoogle Scholar
  167. 167.
    Kyoizumi S, Baum CM, Kaneshima H et al. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 1992; 79: 1704–11.PubMedGoogle Scholar
  168. 168.
    Galy AHM, Webb S, Cen D et al. Generation of T cells from cytokine-mobilized peripheral blood and adult bone marrow CD34’ cells. Blood 1994; 84: 104–110.PubMedGoogle Scholar
  169. 169.
    Namikawa R, Weilbaecher KN, Kaneshima H et al. Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 1990; 172: 1055–63.PubMedCrossRefGoogle Scholar
  170. 170.
    Vandekerckhove BA, Baccala R, Jones D et al. Thymic selection of the human T cell receptor V beta repertoire in SCID-hu mice. J Exp Med 1992; 176: 1619–24.PubMedCrossRefGoogle Scholar
  171. 171.
    Vandekerckhove BA, Jones D, Punnonen J et al. Human Ig production and isotype switching in severe combined immunodeficient-human mice. J Immunol 1993; 151: 128–37.PubMedGoogle Scholar
  172. 172.
    Krowka JF, Sarin S, Namikawa R et al. Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent. J Immunol 1991; 146: 3751–6.PubMedGoogle Scholar
  173. 173.
    Vandekerckhove BA, Krowka JF, McCune JM et al. Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. J Immunol 1991; 146: 4173–9.PubMedGoogle Scholar
  174. 174.
    Peault B, Namikawa R, Krowka J, McCune JM. Experimental human hematopoiesis in immunodeficient SCID mice engrafted with fetal blood-forming organs. In: Edwards RG, ed. Fetal Tissue Transplants in Medicine. Cambridge UK: Cambridge University Press, 1992: 77–95.Google Scholar
  175. 175.
    Namikawa R, Kaneshima H, Lieberman M et al. Infection of the SCIDhu mouse by HIV-1. Science 1988; 242: 1684–6.PubMedCrossRefGoogle Scholar
  176. 176.
    Kaneshima H, Shih C-C, Namikawa R et al. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Proc Natl Acad Sci USA 1991; 88: 4523–7.PubMedCrossRefGoogle Scholar
  177. 177.
    Kaneshima H, Su L, Bonyhadi ML et al. Rapid-high, syncytium-inducing isolates of HIV-1 induce cytopathicity in the human thymus of the SCIDhu mouse. J Virol 1994; 68: 8188–92.PubMedGoogle Scholar
  178. 178.
    Jamieson BD, Aldrovandi GM, Planelles V et al. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol 1994; 68: 3478–85.PubMedGoogle Scholar
  179. 179.
    McCune JM, Namikawa R, Shih C-C et al. Suppression of HIV infection in AZT-treated SCID-hu mice. Science 1990; 247: 564–6.PubMedCrossRefGoogle Scholar
  180. 180.
    Mocarski ES, Bonyhadi M, Salimi S et al. Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc Natl Acad Sci USA 1993; 90: 104–8.PubMedCrossRefGoogle Scholar
  181. 181.
    Kyoizumi S, Murray LJ, Namikawa R. Preclinical analysis of cytokine therapy in the SCID-hu mouse. Blood 1993; 81: 1479–88.PubMedGoogle Scholar
  182. 182.
    Kyoizumi S, McCune JM, Namikawa R. Direct evaluation of radiation damage in human hematopoietic progenitor cells in vivo. Rad Res 1994; 137: 76–83.CrossRefGoogle Scholar
  183. 183.
    Namikawa R, Ueda R, Kyoizumi S. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. Blood 1993; 82: 2526–36.PubMedGoogle Scholar
  184. 184.
    Peault B, Weissman IL, Baum C et al. Lymphoid reconstitution of the human fetal thymus of SCID mice with CD34’ precursor cells. J Exp Med 1991; 174: 1283–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Joseph M. Mccune
  • Hideto Kaneshima

There are no affiliations available

Personalised recommendations